TITLE

Activity—rest stimulation protocol improves cardiac assistance in dynamic cardiomyoplasty

AUTHOR(S)
Rigatelli, Gianluca; Carraro, Ugo; Barbiero, Mario; Zanchetta, Mario; Dimopoulos, Konstantinos; Cobelli, Franco; Riccardi, Riccardo; Rigatelli, Giorgio
PUB. DATE
March 2002
SOURCE
European Journal of Cardio-Thoracic Surgery;Mar2002, Vol. 21 Issue 3, p478
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: No data have ever been published regarding cardiac assistance in demand dynamic cardiomyoplasty (DDCMP). We tested the efficacy of the Doppler flow wire in measuring beat-to-beat aortic flow velocity and evaluating cardiac assistance in demand cardiomyoplasty patients. Methods: The technique was tested in seven patients (M/F=6/1; age=57.1±6.2 years; atrial fibrillation/sinus rhythm=1/6; NYHA=1.4±0.5). Measurements were done using a 0.018 inch peripheral Doppler flow wire advanced through a 5F arterial femoral sheath. Three 1-min periods with the stimulator off and three 1-min periods with clinical stimulation were recorded. We measured peak aortic flow velocity in all beats. Latissimus dorsi (LD) mechanogram was simultaneously recorded. Results: Comparison between pre-operative and follow-up data showed significantly higher values of tetanic fusion frequency (TFF) and ejection fraction at follow-up, whereas mean NYHA class was significantly lower. Statistical analysis showed an increase in aortic flow velocity not only in assisted versus rest period, but also in assisted versus unassisted beats (8.42±6.98% and 7.55±3.07%). A linear correlation was found between the increase in flow velocity and LD wrap TFF (r2=0.53). Conclusions: In DDCMP, systolic assistance is significant and correlated to LD speed of contraction; demand stimulation protocol maintains muscle properties and increases muscle performance.
ACCESSION #
7766952

 

Related Articles

  • Lost in Translation: What is Limiting Cardiomyoplasty and Can Tissue Engineering Help? Simpson, David; Dudley Jr., Samuel C. // Current Stem Cell Research & Therapy;Sep2009, Vol. 4 Issue 3, p210 

    Heart failure accounts for more deaths in the United States than any other detrimental human pathology. Recently, repairing the heart after seemingly irreversible injury leading to heart failure appears to have come within reach. Cellular cardiomyoplasty, transplanting viable cell alternatives...

  • Cardiomyoplasty for treatment of heart failure. Bocchi, Edimar Alcides // European Journal of Heart Failure;Aug2001, Vol. 3 Issue 4, p403 

    The article focuses on cardiomyoplasty for heart failure treatment. It says that studies have postulated that dynamic cardiomyoplasty may work as an active and passive pport of the damaged myocardium. It mentions the effect of the method, including direct synchronized cardiac systolic...

  • Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. Ince, Hüseyin; Petzsch, Michael; Rehders, Tim C.; Chatterjee, Tushar; Nienaber, Christoph A.; Ince, Hüseyin // Journal of Endovascular Therapy (Allen Press Publishing Services;Dec2004, Vol. 11 Issue 6, p695 

    Purpose: To report a case-controlled safety and feasibility study of transcatheter transplantation of autologous skeletal myoblasts as a stand-alone procedure in patients with ischemic heart failure. Methods: Six men (mean age 66.2+/-7.2 years) were eligible for...

  • Now! Surgery for heart failure. Bove, Lisa Anne; O'Connor, Eileen // RN;May95, Vol. 58 Issue 5, p26 

    Informs about cardiomyoplasty, a surgery which can cure patients with refractory and worsening end-stage heart failure. Selection criteria; Meeting patients' needs; Description of the case of George Krebbs, who underwent cardiomyoplasty. INSET: Dynamic cardiomyoplasty: How it's done..

  • Now! Surgery for heart failure. Bove, Lisa Anne; O'Connor, Eileen // RN;May95, Vol. 58 Issue 5, p26 

    Informs about cardiomyoplasty, a surgery which can cure patients with refractory and worsening end-stage heart failure. Selection criteria; Meeting patients' needs; Description of the case of George Krebbs, who underwent cardiomyoplasty. INSET: Dynamic cardiomyoplasty: How it's done..

  • Cell Based Approaches for Myocardial Regeneration and Artificial Myocardium. Genovese, Jorge; Cortes-Morichetti, Miguel; Chachques, Emmanuel; Frati, Giacomo; Patel, Amit; Chachques, Juan C. // Current Stem Cell Research & Therapy;May2007, Vol. 2 Issue 2, p121 

    Ischemic myocardial disease, the main cause of heart failure, is a major public health and economic problem. Given the aging population, heart failure is becoming an increasing clinical issue and a substantial financial burden. Thus, research in heart failure is of relevant interest and...

  • Cellular Cardiomyoplasty and Cardiac Regeneration. Pendyala, Lakshmana; Goodchild, Traci; Gadesam, Radhika R.; Chen, Jack; Robinson, Keith; Chronos, Nicolas; Dongming Hou // Current Cardiology Reviews;2008, Vol. 4 Issue 2, p72 

    Despite of vast improvements in treatment, myocardial infarction often leads to heart failure (HF) which remains the leading cause of death in developed countries. Other than heart transplantation, therapeutic options have a limited role in improving out comes in patients with severe HF. It is...

  • Regenerating functional heart tissue for myocardial repair. Alcon, Andre; Cagavi Bozkulak, Esra; Qyang, Yibing // Cellular & Molecular Life Sciences;Aug2012, Vol. 69 Issue 16, p2635 

    Heart disease is one of the leading causes of death worldwide and the number of patients with the disease is likely to grow with the continual decline in health for most of the developed world. Heart transplantation is one of the only treatment options for heart failure due to an acute...

  • Combined autologous cellular cardiomyoplasty using skeletal myoblasts and bone marrow cells for human ischemic cardiomyopathy with left ventricular assist system implantation: Report of a case. Shigeru Miyagawa; Goro Matsumiya; Toshihiro Funatsu; Masao Yoshitatsu; Naozumi Sekiya; Shinya Fukui; Takaya Hoashi; Masatsugu Hori; Hideki Yoshikawa; Yuzuru Kanakura; Jun Ishikawa; Katsuyuki Aozasa; Naomasa Kawaguchi; Nariaki Matsuura; Akira Myoui; Akifumi Matsuyama; Sachiko Ezoe; Hidehiro Iida; Hikaru Matsuda; Yoshiki Sawa // Surgery Today;Feb2009, Vol. 39 Issue 2, p133 

    Abstract  Myocardial regeneration therapy shows great promise as a treatment for heart failure. We recently introduced combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells as a treatment for human ischemic cardiomyopathy. We report the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics